An Taoiseach, Brian Cowen, TD officially opened Freund Pharmatec’s new European hub in Tullamore, Co Offaly, today. The company’s investment, which is supported by the Irish Government with the aid of IDA, is set to create 25 new jobs.
Freund initially announced its decision to locate in Ireland in January of this year. Headquartered in Tokyo, the pharmaceutical company employs more than 300 people in operations in Japan and the US. The primary focus of the new jobs created in Tullamore will be in new drug delivery technologies and clinical trial manufacturing, as well as a number of positions in marketing/sales of pharmaceutical equipment and excipients.
Commenting at the opening, Cowen said: "This is Freund’s first venture into Europe and the choice of Ireland demonstrates that not only are we very much open for business but continuing to provide a competitive location for foreign direct investment.”
“Freud will be recruiting for high-value positions in the midlands region and as a regional hub, with a skilled and educated workforce, we can ensure the corporation will find the best possible candidates to fill these roles here, in keeping with Ireland’s smart economy reputation,” he added.
Barry O’Leary, CEO, IDA, said: “The choice of Ireland highlights Ireland’s attractiveness for the medical technology sector and Freund is the latest addition to a globally renowned Medical Technology cluster in the midlands region.”
Article courtesy of Businessandleadership.com